Myriad Genetics Reports Fiscal Second-Quarter 2020 Financial Results
Go back to Myriad Genetics Reports Fiscal Second-Quarter 2020 Financial Results| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 3.21 +0.03 (0.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.18 | 52 Week High | $45.34 | |||
| Open | $3.16 | 52 Week Low | $15.92 | |||
| Day High | $3.35 | P/E | 1.38 | |||
| Day Low | $3.16 | EPS | $2.33 | |||
| Volume | 625,087 | |||||

